Literature DB >> 29748901

Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls, while the neuropil is not affected: an autopsy study.

Stefanie Fingerhut1, Michael Sperling1,2, Markus Holling3, Thomas Niederstadt4, Thomas Allkemper4, Alexander Radbruch5,6, Walter Heindel4, Werner Paulus7, Astrid Jeibmann8, Uwe Karst9.   

Abstract

Recent studies showed gadolinium depositions following serial administrations of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging examinations in various parts of the brain with the dentate nucleus (DN) being most affected. Even though no clinical correlates of the deposits are known yet, an intensive debate developed if this might be harmful. The aim of the current study was to specify the gadolinium distribution in brain tissue of patients who received serial injections of GBCAs in the low-µm range and to explore any potential pathological tissue changes caused by gadolinium deposits. Thirteen autopsy cases-eight receiving GBCA administrations, five serving as controls-were identified and analyzed. For all patients, total gadolinium quantification after acidic digestion by means of inductively coupled plasma-mass spectrometry (ICP-MS) was performed. Six cases were utilized for the spatially resolved quantification of gadolinium within the cerebellum and the basal ganglia by means of high-resolution laser ablation (LA)-ICP-MS. Histopathological and immunohistochemical examinations were performed to determine tissue reactions. LA-ICP-MS revealed gadolinium depositions in the walls of small blood vessels of the DN in all GBCA exposed patients, while no gadolinium was found in the control group. Additionally, the detection of phosphorus and metals like copper, zinc and iron provides evidence that transmetalation reactions might have occurred. No significant pathological changes of the brain tissue in the vicinity of the DN with respect to micro-/astrogliosis and neuronal loss were found in any of the patients. This notably holds true even for a patient who died from nephrogenic systemic fibrosis exhibiting extremely high gadolinium concentrations within the DN. The findings show that gadolinium depositions in the brain are restricted to blood vessel walls, while the neuropil is spared and apparent cellular reactions are absent.

Entities:  

Keywords:  Gadolinium retention; High spatial resolution; Histology; LA-ICP-MS

Mesh:

Substances:

Year:  2018        PMID: 29748901     DOI: 10.1007/s00401-018-1857-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

1.  Nonhomogeneous Gadolinium Retention in the Cerebral Cortex after Intravenous Administration of Gadolinium-based Contrast Agent in Rats and Humans.

Authors:  Olga Minaeva; Ning Hua; Erich S Franz; Nicola Lupoli; Asim Z Mian; Chad W Farris; Audrey M Hildebrandt; Patrick T Kiernan; Laney E Evers; Allison D Griffin; Xiuping Liu; Sarah E Chancellor; Katharine J Babcock; Juliet A Moncaster; Hernan Jara; Victor E Alvarez; Bertrand R Huber; Ali Guermazi; Lawrence L Latour; Ann C McKee; Jorge A Soto; Stephan W Anderson; Lee E Goldstein
Journal:  Radiology       Date:  2019-11-26       Impact factor: 11.105

2.  Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.

Authors:  Aida Kiviniemi; Maria Gardberg; Paul Ek; Janek Frantzén; Johan Bobacka; Heikki Minn
Journal:  Neuroradiology       Date:  2019-02-02       Impact factor: 2.804

3.  Gadolinium Deposition Safety: Seeking the Patient's Perspective.

Authors:  C A Mallio; C C Quattrocchi; À Rovira; P M Parizel
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

4.  Differences of radiocarpal cartilage alterations in arthritis and osteoarthritis using morphological and biochemical magnetic resonance imaging without gadolinium-based contrast agent administration.

Authors:  Valentina Mori; Lino M Sawicki; Philipp Sewerin; Markus Eichner; Benedikt M Schaarschmidt; Lisa Oezel; Sebastian Gehrmann; Bernd Bittersohl; Gerald Antoch; Christoph Schleich
Journal:  Eur Radiol       Date:  2018-12-12       Impact factor: 5.315

5.  Next-Generation Cancer Magnetic Resonance Imaging With Tumor-Targeted Alkylphosphocholine Metal Analogs.

Authors:  Ray R Zhang; Cynthia Choi; Christina L Brunnquell; Reinier Hernandez; Anatoly N Pinchuk; Joseph G Grudzinski; Paul A Clark; Alan B McMillan; Anjon Audhya; Justin Jeffrey; John S Kuo; Jamey P Weichert
Journal:  Invest Radiol       Date:  2022-06-22       Impact factor: 10.065

6.  Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.

Authors:  Mark C DeLano; Maria Vittoria Spampinato; Eric Y Chang; Richard G Barr; Richard J Lichtenstein; Cesare Colosimo; Josef Vymazal; Zhibo Wen; Doris D M Lin; Miles A Kirchin; Gianpaolo Pirovano
Journal:  J Magn Reson Imaging       Date:  2021-05-20       Impact factor: 5.119

7.  Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma.

Authors:  Rameshwar Patil; Anna Galstyan; Zachary B Grodzinski; Ekaterina S Shatalova; Shawn Wagner; Liron L Israel; Hui Ding; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Int J Nanomedicine       Date:  2020-05-01

8.  MR signal intensity: staying on the bright side in MR image interpretation.

Authors:  Johan L Bloem; Monique Reijnierse; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  RMD Open       Date:  2018-06-20

9.  Investigation of potential adverse central nervous system effects after long term oral administration of gadolinium in mice.

Authors:  Dominik Nörenberg; Felix Schmidt; Karin Schinke; Thomas Frenzel; Hubertus Pietsch; Armin Giese; Birgit Ertl-Wagner; Johannes Levin
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

Review 10.  Retention of Gadolinium in Brain Parenchyma: Pathways for Speciation, Access, and Distribution. A Critical Review.

Authors:  Marlène Rasschaert; Roy O Weller; Josef A Schroeder; Christoph Brochhausen; Jean-Marc Idée
Journal:  J Magn Reson Imaging       Date:  2020-04-04       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.